Docon Technologies Private Limited has announced the full release of a pledge on 7,94,69,696 equity shares of Thyrocare Technologies Limited. The pledge was created as security for Non-Convertible Debentures (NCDs) issued by API Holdings Limited, which have now been fully redeemed. This release means no outstanding pledge or encumbrance remains on Docon’s shareholding in Thyrocare, significantly de-risking its stake as of August 17, 2026.
Pledge on Thyrocare Shares Fully Released
Docon Technologies Private Limited has officially communicated the complete release of a pledge that was previously placed on 7,94,69,696 equity shares of its subsidiary, Thyrocare Technologies Limited. The pledge was initiated to secure the financial obligations related to Non-Convertible Debentures (NCDs) issued by API Holdings Limited, the holding company. This development, effective as of August 17, 2026, signifies a substantial reduction in the promoter’s financial encumbrances.
Background of the Pledge and Redemption
The NCDs in question had an outstanding principal amount of INR 10,500 million. API Holdings Limited successfully redeemed and repaid these NCDs in full on August 14, 2026. Following this comprehensive repayment, the pledge that Docon Technologies had placed on its Thyrocare equity shares in favour of Catalyst Trusteeship Limited, acting as the Debenture Trustee, has been entirely extinguished. This action removes any prior encumbrance associated with these specific NCDs.
Current Shareholding Status
As of August 17, 2026, Docon Technologies confirms that its entire shareholding in Thyrocare Technologies Limited, related to the aforementioned NCDs, is now free of any pledges. The company also stated that there are no other outstanding pledges or encumbrances by the promoter over the share capital of Thyrocare. Docon continues to hold 8,12,00,000 equity shares, representing 51.02% of Thyrocare’s total share capital, with no shares remaining encumbered.
Disclosure Compliance
This disclosure has been made in compliance with Regulations 29(2), 31(2), and 31(3) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The necessary disclosures, including details of the release event and the current shareholding structure, are provided in the annexures to this announcement.
Source: BSE
